Director of Integration & Editor-in-Chief:
Peter is the Editor-in-Chief of PharmSource and he is also leading the integration of BioPharm Insight, Lead Sheet and PharmSource into GlobalData. Peter previously served as the Director for the Drug, Companies, News and Deals databases for GlobalData’s Pharma Intelligence Center.
Prior to joining GlobalData, Peter was an Assistant Manager at Target Health, a Contract Research Organization (CRO) where he helped a diverse set of clients with the demands of bringing biologics, devices, and drugs to the market successfully. Peter also worked in small molecule drug development for Abbott Labs and on in vitro diagnostics at Ambergen, a diagnostic startup.
Peter holds a PhD in Molecular and Cellular Biology from the Sackler Institute of New York University and is located in GlobalData’s office in New York City.
Founder & President Emeritus:
Jim Miller, MBA
Jim Miller is the founder and former president of PharmSource. A preeminent expert in bio/pharmaceutical outsourcing, Jim established the industry’s principal resource for serious consumers of information on contract drug development and manufacturing, PharmSource
Jim served as an Editorial Advisory Board member for Advanstar Communication’s Pharmaceutical Technology and BioPharm magazines. He wrote regular columns on outsourcing for Pharmaceutical Technology, Contract Services Europe and BioPharm magazines. Jim chaired the advisory committee of the Pharma & Biopharma Outsourcing Association (PBOA). He served on the board of directors of the American Type Culture Collection (ATCC) from 2007 until 2016.
Jim formerly was Vice President of Sales and Marketing at Circa Pharmaceuticals, Inc., a solid dose manufacturer. Prior to that, he was President of St. Anthony Publishing, a provider of database information services for the health care industry. He also was a consultant in corporate strategy with the Boston Consulting Group. Jim holds an MBA degree from the Stanford University Graduate School of Business
Editorial Advisory Board Members:
A consultant in sourcing of pharmaceutical products, John is located in West Chester, PA. He formerly was Senior Director of Strategic Sourcing for DuPont Pharmaceuticals, which outsources all of its API and intermediate manufacturing requirements. John has more than 20 years’ experience in discovery, process development, manufacturing and procurement.
Mak Jawadekar, PhD
An independent pharmaceutical industry consultant, Mak currently serves on several US and international company boards in scientific advisory and business management capacities. After 28 years of tenure at Pfizer Inc., in March 2010, he opted to take early retirement. Mak was a Director, Portfolio Management & Performance with the World Wide Businesses (Commercial) Division of Pfizer Inc. in New London, CT, where he was involved in R&D benchmarking metrics for speed, quality & costs to enhance Pharmaceutical R&D productivity.
Mak also advised Pfizer’s R&D business on system solution approaches and best practices, and served as an advisor to Pfizer’s President of R&D on Asia-related strategic matters. Prior to that, he spent many years with Pfizer’s Pharm Sciences Group as a leader, where he held responsibility for Strategic Outsourcing of Drug Products activities and Drug Delivery Technology Assessment functions. Mak also managed strategic-level decisions on external alliances and collaborations, including partnerships, due diligence activities, and licensing & development. His extensive previous experience includes dosage form development/formulations/drug delivery R&D, clinical manufacturing, tech transfer and scale-up operations, and work with Pfizer Global Manufacturing.
Martin L. Jeiven, MS
Marty is the President of Jeiven Pharmaceutical Consulting, Inc. (JPC), which specializes in clinical materials management. He also presides over Pharmaceutical Training Seminars, Inc., which provides GMP training services. JPC helps its clients identify, audit, and select contract manufacturers and clinical packagers; provides “man in the plant” services during production operations; and provides GMP compliance training. Prior to starting his own company, Marty was Manager of Clinical and Pre-Clinical Materials at RW Johnson Pharmaceutical Research Institute.
Howard L. Levine, PhD
Howard is the President of BioProcess Technology Consultants, a consulting firm specializing in biopharmaceutical process development, manufacturing, and engineering. Previously, Howard was Vice President of Manufacturing Operations at Repligen Corporation, and has worked for Amgen, Genentech, and Xoma. He has lectured extensively on downstream processing and manufacturing in biotechnology.
Paul C. Stuart
Paul has over 20 years of experience in the pharmaceutical industry at Procter and Gamble Company, Inc., and Pfizer, Inc. He has held leadership roles in technical product development, business management, outsourcing management, finance, and supply chain management.
Paul currently serves as Vice President of the Clinical Supply Chain at Pfizer Worldwide R&D, where he is responsible for all drug product manufacturing, inventory management, distribution, and sourcing activities in support of clinical trials global-wide. Paul manages the internal R&D drug product manufacturing assets and inventory facilities, and a broad network of contract service providers in the areas of manufacturing and distribution. His group supports clinical supply needs across all phases of development, including pre-registration programs in Phase I-III, and post-marketing Phase IV studies.
Peter is president of xCell Strategic Consulting, which provides strategy development and operational improvement services to bio/pharmaceutical and other life sciences companies. Peter has held executive leadership roles and provided management consultation within the biopharmaceutical, healthcare and consumer goods industries for over 28 years. His executive positions have included President, North America Commercial Operations and Interim CEO of Patheon, a leading CMO; Sr. Vice President of Manufacturing for Wyeth Pharmaceuticals, and President of the Qualitest division of Endo Pharmaceuticals.
Peter holds a BSME, Mechanical Engineering from Villanova University and a Master’s Degree, Business Administration and Management from Philadelphia University.
PharmSource Professional Staff:
Fiona Barry, MA
Fiona Barry is the Associate Editor of PharmSource and based in GlobalData’s London office. Fiona previously worked as an investigative journalist for the drug development news service BioPharm Insight, reporting on clinical trials, contract pharma, rare disease and women’s health. She has also worked in France as a reporter at William Reed Business Media, covering global manufacturing, regulatory and outsourcing news for the biopharmaceutical industry.
She holds an M.A. in English and a B.A. in English and Philosophy from Bristol University. She speaks English and French.
Kathryn Kinch, BA
Kathryn Kinch is the Research Manager for Lead Sheet and BioPharm Insight analyst teams. Prior to this role, she worked as a Research Manager for Infinata Healthcare. Since the acquisition of Infinata by GlobalData in 2017, Kathryn has been involved in the integration of Infinata Healthcare products into GlobalData and the development of their research team.
Kathryn holds a B.A. in English from Bridgewater State University and is located in GlobalData’s Boston office.
Adam Bradbury, MSc
Adam Bradbury currently serves as Associate Analyst for the PharmSource database where his primary responsibilities include maintenance, improvement and analysis of the Contract Manufacturing datasets. Adam has published numerous market research reports and has been involved in database improvements and integration for GlobalData’s Pharma Intelligence Center.
Adam Bradbury holds an MSc in Human Molecular Genetics from Imperial College London and is located in GlobalData’s London office.